Cellular source(s) of platelet-activating-factor acetylhydrolase activity in plasma

Koichiro Asano, Shinichiro Okamoto, Koichi Fukunaga, Tetsuya Shiomi, Takehiko Mori, Makiko Iwata, Yasuo Ikeda, Kazuhiro Yamaguchi

Research output: Contribution to journalArticle

126 Citations (Scopus)

Abstract

Platelet activating factor (PAF) is immediately degraded and inactivated in the bloodstream by plasma PAF acetylhydrolase (PAF-AH). Although plasma PAF-AH-like activity was secreted in vitro from various cell types such as macrophages and hepatocytes, the exact cellular source(s) of this enzyme activity in vivo remains unclear. There is a naturally-occurring missense mutation (V279F) in the plasma PAF-AH gene in the Japanese population which results in complete loss of the enzyme activity. We analyzed 52 Japanese who had received an allogeneic bone marrow transplant and maintained donor-derived hematopoiesis. Ten recipients had chimeric plasma PAF-AH genotypes between the donor-derived peripheral blood leukocytes and the recipient-derived epithelial cells of buccal mucosa. Multiple regression analysis demonstrated that PAF-AH activity in plasma depended on the donor's genotype (standardized regression coefficient = 0.68, P < 0.0001), but not on the recipient's genotype (p = 0.48). One recipient who was a V279F homozygote in leukocytes and wild type homozygote in buccal mucosa had undetectable PAF-AH activity in plasma. We conclude that most of the PAF-AH activity in human plasma originates from hematopoietic lineage cells.

Original languageEnglish
Pages (from-to)511-514
Number of pages4
JournalBiochemical and Biophysical Research Communications
Volume261
Issue number2
DOIs
Publication statusPublished - 1999 Aug 2

Fingerprint

Platelet Activating Factor
Plasmas
Genotype
Homozygote
Mouth Mucosa
Enzyme activity
Leukocytes
Plasma (human)
Transplants
Macrophages
Hematopoiesis
Missense Mutation
Enzymes
Human Activities
Regression analysis
Hepatocytes
Bone
Blood
Genes
Bone Marrow

Keywords

  • Bone marrow transplantation
  • Hepatocytes
  • Macrophages

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology

Cite this

Cellular source(s) of platelet-activating-factor acetylhydrolase activity in plasma. / Asano, Koichiro; Okamoto, Shinichiro; Fukunaga, Koichi; Shiomi, Tetsuya; Mori, Takehiko; Iwata, Makiko; Ikeda, Yasuo; Yamaguchi, Kazuhiro.

In: Biochemical and Biophysical Research Communications, Vol. 261, No. 2, 02.08.1999, p. 511-514.

Research output: Contribution to journalArticle

Asano, Koichiro ; Okamoto, Shinichiro ; Fukunaga, Koichi ; Shiomi, Tetsuya ; Mori, Takehiko ; Iwata, Makiko ; Ikeda, Yasuo ; Yamaguchi, Kazuhiro. / Cellular source(s) of platelet-activating-factor acetylhydrolase activity in plasma. In: Biochemical and Biophysical Research Communications. 1999 ; Vol. 261, No. 2. pp. 511-514.
@article{f550ce6775bc416f855cf4b98d03d8f2,
title = "Cellular source(s) of platelet-activating-factor acetylhydrolase activity in plasma",
abstract = "Platelet activating factor (PAF) is immediately degraded and inactivated in the bloodstream by plasma PAF acetylhydrolase (PAF-AH). Although plasma PAF-AH-like activity was secreted in vitro from various cell types such as macrophages and hepatocytes, the exact cellular source(s) of this enzyme activity in vivo remains unclear. There is a naturally-occurring missense mutation (V279F) in the plasma PAF-AH gene in the Japanese population which results in complete loss of the enzyme activity. We analyzed 52 Japanese who had received an allogeneic bone marrow transplant and maintained donor-derived hematopoiesis. Ten recipients had chimeric plasma PAF-AH genotypes between the donor-derived peripheral blood leukocytes and the recipient-derived epithelial cells of buccal mucosa. Multiple regression analysis demonstrated that PAF-AH activity in plasma depended on the donor's genotype (standardized regression coefficient = 0.68, P < 0.0001), but not on the recipient's genotype (p = 0.48). One recipient who was a V279F homozygote in leukocytes and wild type homozygote in buccal mucosa had undetectable PAF-AH activity in plasma. We conclude that most of the PAF-AH activity in human plasma originates from hematopoietic lineage cells.",
keywords = "Bone marrow transplantation, Hepatocytes, Macrophages",
author = "Koichiro Asano and Shinichiro Okamoto and Koichi Fukunaga and Tetsuya Shiomi and Takehiko Mori and Makiko Iwata and Yasuo Ikeda and Kazuhiro Yamaguchi",
year = "1999",
month = "8",
day = "2",
doi = "10.1006/bbrc.1999.1066",
language = "English",
volume = "261",
pages = "511--514",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Cellular source(s) of platelet-activating-factor acetylhydrolase activity in plasma

AU - Asano, Koichiro

AU - Okamoto, Shinichiro

AU - Fukunaga, Koichi

AU - Shiomi, Tetsuya

AU - Mori, Takehiko

AU - Iwata, Makiko

AU - Ikeda, Yasuo

AU - Yamaguchi, Kazuhiro

PY - 1999/8/2

Y1 - 1999/8/2

N2 - Platelet activating factor (PAF) is immediately degraded and inactivated in the bloodstream by plasma PAF acetylhydrolase (PAF-AH). Although plasma PAF-AH-like activity was secreted in vitro from various cell types such as macrophages and hepatocytes, the exact cellular source(s) of this enzyme activity in vivo remains unclear. There is a naturally-occurring missense mutation (V279F) in the plasma PAF-AH gene in the Japanese population which results in complete loss of the enzyme activity. We analyzed 52 Japanese who had received an allogeneic bone marrow transplant and maintained donor-derived hematopoiesis. Ten recipients had chimeric plasma PAF-AH genotypes between the donor-derived peripheral blood leukocytes and the recipient-derived epithelial cells of buccal mucosa. Multiple regression analysis demonstrated that PAF-AH activity in plasma depended on the donor's genotype (standardized regression coefficient = 0.68, P < 0.0001), but not on the recipient's genotype (p = 0.48). One recipient who was a V279F homozygote in leukocytes and wild type homozygote in buccal mucosa had undetectable PAF-AH activity in plasma. We conclude that most of the PAF-AH activity in human plasma originates from hematopoietic lineage cells.

AB - Platelet activating factor (PAF) is immediately degraded and inactivated in the bloodstream by plasma PAF acetylhydrolase (PAF-AH). Although plasma PAF-AH-like activity was secreted in vitro from various cell types such as macrophages and hepatocytes, the exact cellular source(s) of this enzyme activity in vivo remains unclear. There is a naturally-occurring missense mutation (V279F) in the plasma PAF-AH gene in the Japanese population which results in complete loss of the enzyme activity. We analyzed 52 Japanese who had received an allogeneic bone marrow transplant and maintained donor-derived hematopoiesis. Ten recipients had chimeric plasma PAF-AH genotypes between the donor-derived peripheral blood leukocytes and the recipient-derived epithelial cells of buccal mucosa. Multiple regression analysis demonstrated that PAF-AH activity in plasma depended on the donor's genotype (standardized regression coefficient = 0.68, P < 0.0001), but not on the recipient's genotype (p = 0.48). One recipient who was a V279F homozygote in leukocytes and wild type homozygote in buccal mucosa had undetectable PAF-AH activity in plasma. We conclude that most of the PAF-AH activity in human plasma originates from hematopoietic lineage cells.

KW - Bone marrow transplantation

KW - Hepatocytes

KW - Macrophages

UR - http://www.scopus.com/inward/record.url?scp=0033517041&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033517041&partnerID=8YFLogxK

U2 - 10.1006/bbrc.1999.1066

DO - 10.1006/bbrc.1999.1066

M3 - Article

C2 - 10425216

AN - SCOPUS:0033517041

VL - 261

SP - 511

EP - 514

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 2

ER -